Evidence map›Paper›PMID 18161013›Full record

ArticlePharmaceutical research2008

Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.

Yogeeta Narkar, Ronald Burnette, Reiner Bleher, Ralph Albrecht, Angki Kandela, Joseph R Robinson

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yogeeta NarkarProduct Development, Actavis, Owings Mills, MD 21117, USA. ynarkar@actavis.com
Ronald Burnette
Reiner Bleher
Ralph Albrecht
Angki Kandela
Joseph R Robinson
University of Wisconsin–Madison · USInstitute for Advanced Journalism Studies · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate absorption barrier recovery in the gastrointestinal tract after treatment with a penetration enhancer by using a poorly absorbed marker and correlate results with morphological recovery.

methodsOral gavage of sodium dodecyl sulfate (SDS) was given to Wistar rats. Phenol red (PR) was given at different time points following administration of SDS. Blood samples were obtained from the jugular vein. Pharmacokinetic analysis was performed on the in vivo data using WinNonlin and MATLAB5 software. The pharmacokinetic parameters of PR were compared to the negative control to measure functional recovery. The intestinal tissues were observed using light and transmission electron microscopy.

resultsAbsorption was highest when PR was co-administered with SDS. C (max), AUC and K (a) decreased and T (max) and MAT increased as the recovery period (time between administration of SDS and PR) increased. The pharmacokinetic parameters approached the negative control profile in one hour after treatment with 1% SDS. Microscopy results showed recovery of paracellular and transcellular barrier at this time.

conclusionsAbsorption barrier recovery could be measured using a poorly absorbed marker. Functional recovery showed a good correlation with morphological recovery. The local effects of SDS were found to be temporary and reversible.

Indexed as

AnimalsArea Under CurveColoring AgentsExcipientsIntestinal AbsorptionIntestinal MucosaMicroscopy, Electron, TransmissionPhenolsulfonphthaleinRatsRats, WistarSodium Dodecyl SulfateSurface-Active AgentsColoring AgentsExcipientsPhenolsulfonphthaleinSodium Dodecyl SulfateSurface-Active Agents

Identifiers

PMID18161013
OpenAlexW1980405222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.